Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome
Alexander Zimprich(Ludwig-Maximilians-Universität München), Thomas Gasser(Hertie Institute for Clinical Brain Research), Mirna Castro(Ludwig-Maximilians-Universität München), Friedrich Asmus(Ludwig-Maximilians-Universität München), Juliane Winkelmann(Helmholtz Zentrum München), Bertram Müller‐Myhsok(Max Planck Institute of Psychiatry), Leonhard Riedel(Ludwig-Maximilians-Universität München), Tanja R. Müller(Center for Global Development), Peter Kern(St. Elisabeth-Hospital Bochum), Matthias Bauer(Ludwig-Maximilians-Universität München), Markus Bertram(Heidelberg University), Tim M. Strom(Ludwig-Maximilians-Universität München), Monika Grabowski(TUM Klinikum), K H Scheidtmann(Schön Klinik Bad Aibling), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Markus Naumann(University Hospital Augsburg), Thomas Meitinger(Helmholtz Zentrum München)
Cited by 480
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k